Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure

被引:55
|
作者
Sanaka, T [1 ]
Funaki, T [1 ]
Tanaka, T [1 ]
Hoshi, S [1 ]
Niwayama, J [1 ]
Taitoh, T [1 ]
Nishimura, H [1 ]
Higuchi, C [1 ]
机构
[1] Tokyo Womens Med Univ, Daini Hosp Med Ctr, Dept Nephrol & Blood Purificat, Arakawa Ku, Tokyo 1168567, Japan
来源
NEPHRON | 2002年 / 91卷 / 01期
关键词
pentosidine; enzyme-linked immunosorbent assay; phosphatidylcholine hydroperoxide; chronic renal failure;
D O I
10.1159/000057606
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The plasma pentosidine levels in patients with renal disease were measured by a simple method which was established for plasma and urinary pentosidine determinations. The method, which can be completed within a few hours, involves pretreating plasma with proteolytic enzyme (pronase) and measuring the concentration of pentosidine in the sample by ELISA using antipentosidine antibodies. The prepared antibodies showed no cross-reaction with the raw materials for pentosidine synthesis or with compounds having similar structures. SIDS-PAGE indicated that the antibodies had a high purity. The reaction of the antibodies and keyhole limpet hemocyanin-pentosidine in the competitive ELISA system was inhibited by free pentosidine. Excellent standard curves for pentosidine determination were obtained. In actual measurements of clinical samples from patients, a good correlation (r=0.9356) was obtained between the values measured by ELISA and HPLC. The plasma pentosidine level in patients with renal disease correlated significantly with plasma creatinine, urea nitrogen, beta(2)-Microglobulin, and creatinine clearance, indicating its usefulness in evaluating the severity of renal disease. A significant elevation in plasma pentosidine levels was observed in mild renal dysfunction, whereas no significant increases in creatinine and urea nitrogen levels were detected, suggesting that the plasma pentosidine level is useful in the early diagnosis of beginning renal failure. In patients with chronic renal failure, no difference in plasma pentosidine levels was observed between diabetic nephropathy and chronic glomerulonephritis, while a significant correlation was observed with phosphatidylcholine hydroperoxide, suggesting the possibility that the plasma pentosidine level reflects injury due to oxidation. From these results, the quantitative measurement method developed by us is judged to be a superior innovation for measuring pentosidine in body fluids. The plasma pentosidine level may be useful for the early diagnosis of mild renal failure and to estimate the degree of the severity of renal diseases. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 50 条
  • [21] Serum magnesium levels in patients with chronic renal failure
    Dosoo, DK
    Nunoo, A
    Amanquah, SD
    CLINICAL CHEMISTRY, 2004, 50 (06) : A57 - A57
  • [22] Blood aluminium levels in patients with chronic renal failure
    Smalinskiene, A.
    Abdrakhmanov, O.
    Ryselis, S.
    Kregzdyte, R.
    Skarupskiene, I.
    Kuzminskis, V.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 : 149 - 150
  • [23] IGE LEVELS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    DRATWA, M
    TIELEMANS, C
    BRENEZ, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16): : 960 - 961
  • [24] Decreased fecal human defensin-5 levels in patients with infectious diarrhea using a newly developed ELISA technique.
    Shen, L.
    Jiang, Z.
    Kiran, R.
    Bevins, C.
    DuPont, H.
    Poptic, E.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S18 - S18
  • [25] Plasma lipoproteins in patients with chronic renal failure (CRF)
    Kimak E.
    Solski J.
    Janicka L.
    Duma D.
    Zagojska M.
    International Urology and Nephrology, 1997, 29 (5) : 597 - 601
  • [26] Plasma pteridine concentrations in patients with chronic renal failure
    Yokoyama, K
    Tajima, M
    Yoshida, H
    Nakayama, M
    Tokutome, G
    Sakagami, H
    Hosoya, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (06) : 1032 - 1036
  • [27] Plasma antioxidant activity in patients with chronic renal failure
    MimicOka, J
    Simic, T
    Blagojevic, D
    Coban, J
    Trbojevic, S
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1996, 15 (04): : 202 - 202
  • [28] Accumulation of Scandium in Plasma in Patients with Chronic Renal Failure
    Sanchez-Gonzalez, Cristina
    Lopez-Chaves, Carlos
    Rivas-Garcia, Lorenzo
    Galindo, Pilar
    Gomez-Aracena, Jorge
    Aranda, Pilar
    Llopis, Juan
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [29] Long-Term Plasma Levels and Dose Modulation of Alacepril in Patients with Chronic Renal Failure
    Hiroshi Nonoguchi
    Shigeru Kiyama
    Kenichiro Kitamura
    Masahiro Naruse
    Masao Tomita
    Noboru Tazoe
    Munemasa Tajiri
    Yushi Nakayama
    Yukimasa Kohda
    Takeaki Inoue
    Kimio Tomita
    Hypertension Research, 2008, 31 : 29 - 36
  • [30] Failure of endogenous blood kinin levels elevated by captopril to induce hypotension in normotensive and hypertensive rats: A study using a newly developed ELISA for kinin
    Majima, M
    Katori, M
    Ogino, M
    Saito, M
    Sugimoto, K
    Adachi, K
    Ohno, T
    Sunahara, N
    Katoh, K
    Tatemichi, N
    Takei, Y
    BIOMEDICAL RESEARCH-TOKYO, 1996, 17 (01): : 15 - 25